SUMER JACQUELYN L
Chief Legal Officer
SUMER JACQUELYN L has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.
On the most recent filing, SUMER JACQUELYN L is listed as Chief Legal Officer at Cullinan Therapeutics, Inc. Inside the rolling window, SUMER JACQUELYN L reported no open-market purchases and 3 open-market sales totaling $137K in CGEM. The largest disclosed transaction in the window is a sale of 3,601 CGEM shares on Feb 24, 2026, worth $52K.
Companies traded
Other insiders at CGEM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$137K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SUMER JACQUELYN L made?
SUMER JACQUELYN L has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does SUMER JACQUELYN L trade?
SUMER JACQUELYN L has filed SEC Form 4 disclosures for 1 company, including CGEM.
When was SUMER JACQUELYN L's most recent SEC Form 4 filing?
SUMER JACQUELYN L's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.
What is SUMER JACQUELYN L's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, SUMER JACQUELYN L is listed as Chief Legal Officer.
What is SUMER JACQUELYN L's total buy and sell value in the current window?
Inside the rolling retention window, SUMER JACQUELYN L bought $0 and sold $137K based on SEC Form 4 filings.
What was SUMER JACQUELYN L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,601 CGEM shares on 2026-02-24, worth $52K, per SEC Form 4 filings.